Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative liraglutide for prevention of postoperative delirium after cardiac surgery in older adults with type 2 diabetes
ChiCTR2400083284Phase 4Not yet recruiting
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Apr 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial in postoperative delirium (POD) comparing Liraglutide Group with Vehicle Group (2 arms). Primary endpoint: Incidence of delirium within 7 days postoperatively. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on ChiCTR2400083284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083284.